Lord Saatchi yesterday said that he was “grateful” and “delighted” that the Government was making “a decisive movement to take the Bill forward”
The strength of public support for the Medical Innovation Bill (Saatchi Bill) has persuaded the Government to offer legislation along the lines of the Medical Innovation Bill, following a public consultation to start in January 2014 and report no later than May.
Allowing doctors to test innovative drugs on patients without the fear of being sued would be a “huge stride forward” in the quest to find cures for cancer
said Lord Saatchi
Read Law may change so doctors can test new drugs on patients
by Georgia Graham, The Telegraph, 22 Nov 2013
Read Your support won the Government consultation for the Saatchi Bill
by Saatchi Bill Tumblr
Related post: Cancer Treatment in UK: we do not know the whole Truth says Lord Saatchi
Posted by Dominique “DES Daughter” Le Metayer on 24/11/2013
The CDF will be extended until 2016
An emergency £200m-a-year fund for life-enhancing cancer drugs is to continue until 2016 – after the NHS’s rationing body failed to clear any medicines sent for approval in the past year – the prime minister has announced.
The Cancer Drugs Fund (CDF) was set up in 2011 to help patients in England access certain drugs before they get approval for widespread NHS use – and/or pay for treatments denied to NHS patients by the National Institute for Health and Care Excellence (NICE).
Read Cancer drugs fund ‘to be extended’ until 2016
BBC News Health, 28 Sept 2013
Read NICE under fire for veto of ELEVEN new cancer drugs as £2m fund to tackle illness is extended, 28 Sept 2013
Posted by Dominique “DES Daughter” Le Metayer on 28/09/2013
Breast cancer is the most common cancer in the UK
A new breast cancer test – Oncotype DX - that could spare thousands of women the ordeal of chemotherapy has been approved – by the National Institute for Health and Care Excellence (NICE) - for use in the NHS in England and Wales.
The test works out the odds of a some tumours spreading round the body and should help doctors decide more accurately which patients will need chemotherapy.
Read ‘Chemotherapy-sparing’ test offered, by James Gallagher, BBC News, 26 Sept 2013
Sources: Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat
NICE, September 2013
DES and Breast Cancer:
Posted by Dominique “DES Daughter” Le Metayer on 27/09/2013
Find out more about cervical cancer symptoms, causes and prevention
Cervical cancer is a form of cancer that develops in a woman’s cervix, the vagina’s entrance to the womb.
Described as “uncommon” by the NHS, cervical cancer claims the lives of 1,000 women in the UK each year and remains the most common form of cancer for women under 35.
To mark gynaecological cancer awareness month HuffPost UK Lifestyle spoke to Martin Ledwick, Cancer Research UK’s head information nurse and Robert Music, chief executive of Jo’s Cervical Cancer Trust, to find out more about symptoms, causes and prevention.
Read Cervical Cancer: Spot The Symptoms, Prevent With Cervical Screening And HPV Awareness
by Brogan Driscoll, 11 Sept 2013
For DES Daughters, and in the UK
Posted by Dominique “DES Daughter” Le Metayer on 11/09/2013
Can you spare one day to help Save our NHS? Join the protest outside the Conservative Party conference in Manchester on Sunday 29 September at 08:00-20:00.
Posted by Dominique “DES Daughter” Le Metayer on 15/08/2013
Screening is recommended for women aged between 50 and 70
The findings of a study examining 39 years of breast cancer death rates have hit the headlines, with The Guardian reporting that, ‘Breast cancer screening not shown to reduce deaths.’ The value of breast cancer screening has been the subject of debate for many years.
While the overall reporting on the findings of the review was accurate, most of the headlines focused on the negative findings – the problem of overdiagnosis. The NHS shares its views on the findings of the independent panel that reviewed the benefits and harms of breast cancer screening in the UK.
In the article “Breast cancer screening may not reduce deaths“, the NHS responds to the following questions:
- Where did the story come from?
- What kind of research was this?
- What did the research involve?
- What were the basic results?
- How did the researchers interpret the results?
Analysis by Bazian, NHS Choices
Posted by Dominique “DES Daughter” Le Metayer on 13/06/2013
Doctors must be more sympathetic to pregnant women in danger of losing their babies, according to NICE
The National Institute for Health and Clinical Excellence believes doctors do not give enough information or support to women at risk of miscarriages or ectopic pregnancies. NICE says that the NHS should consider setting up dedicated services for pregnant women who may have an ectopic pregnancy or who experience pain or bleeding in their first trimester. This is according to their December 2012 guideline on the diagnosis and management of ectopic pregnancy and miscarriage in early pregnancy.
Sadly for many DES daughters having their own children is not possible! Many of us who have experienced miscarriages, want to have kids but are struggling or unable to…
Posted by Dominique “DES Daughter” Le Metayer on 06/06/2013
UK NHS ‘masking’ number of patients dying of cancer treatment, warns Lord Saatchi
Lord Saatchi, who is attempting to introduce new legislation to enable doctors to carry out alternative treatments without fear of litigation, said that more than 15,000 people could be dying annually in the UK because of cancer treatments rather than the illness itself, but official figures only classify the underlying cancer as the cause of death.
Read 15,000 people die every year because of cancer treatments, Lord Saatchi says, The Telegraph, by Steven Swinford, 20 May 2013
Read NHS ‘Masking’ Number Of Patients Dying Of Cancer Treatment, Warns Lord Saatchi, The Huffington Post UK, 21 May 2013
Posted by Dominique “DES Daughter” Le Metayer on 21/05/2013
International Clinical Trials Day
International Clinical Trials Day is celebrated around the world on or near the 20 May each year, to commemorate the day that James Lind started his famous trial on the deadly disease scurvy. It provides a focal point to raise awareness of the importance of research to health care, and highlights how partnerships between patients and healthcare practitioners are vital to high-quality, relevant research.
Find out more:
Posted by Dominique “DES Daughter” Le Metayer on 20/05/2013
Promote the OK to ask campaign across the country.
During 2013/14 The National Institute for Health Research (NIHR) is promoting the fact that it’s OK to ask about clinical research. The campaign is aimed at patients, medical professionals and the public. Everyone can get involved and help spread the word that it’s OK to ask about clinical research. f you have a medical condition and are undergoing treatment, the NHS would like you to ask your family doctor, nurse or consultant about clinical research, and whether it might be right for you.
Find out more:
Posted by Dominique “DES Daughter” Le Metayer on 10/05/2013